This site is intended for healthcare professionals only
LoginRegister

LIC reduces stake in Sun Pharma; sells shares worth Rs 3,821 crore in over 1 year

Ruchika SharmaWritten by Ruchika Sharma   |  
LIC reduces stake in Sun Pharma; sells shares worth Rs 3,821 crore in over 1 year
  • whatsapp
  • Telegram

The shares were sold at an average price of Rs 808.02 apiece, valuing the transactions at a total of Rs 3,881.85 crore.

New Delhi: Life Insurance Corporation on Monday said it has reduced shareholding in Sun Pharmaceuticals by selling 2 percent stake in the company for about Rs 3,882 crore. The shares were sold through open market transactions during the period from May 17, 2021 to July 22, 2022, according to a regulatory filing.

"This is to inform that corporation's shareholding in Sun Pharmaceuticals has diluted from 16,85,66,486 to 12,05,24,944 equity shares, decreasing its shareholding from 7.026 per cent of the paid-up capital of the said company," it said.
Under Sebi norms, listed companies are required to intimate the stock exchanges when their shareholding in an entity falls by 2 percent or more.
The shares were sold at an average price of Rs 808.02 apiece, valuing the transactions at a total of Rs 3,881.85 crore.
On the BSE, shares of LIC (Life Insurance Corporation) declined 0.70 per cent to close at Rs 684.15 apiece while that of Sun Pharmaceuticals fell 0.75 per cent to Rs 868.05 apiece.

Read also: Sun Pharma plans to increase field force in India by 10 percent in current fiscal

Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates.

Read also: Sun Pharma expects high single-digit top-line growth in FY23

Life Insurance CorporationLife InsuranceSun PharmaSun Pharma newsLIC
Source : with inputs
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    X